Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 3, 2005, Pages 310-315

  Terzoli, Laura ^a   Mircoli, Luca ^c,d   Raco, Roberta ^a   Ferrari, Alberto U ^a,b,d  

^a DESIO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d Centro di Fisiologia Clinica e Ipertensione   (Italy)

Author keywords

Ambulatory blood pressure; Cardiovascular prevention; Cholesterol; Statins

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATIDYLCHOLINE; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART PROTECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES;

EID: 24344440634     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000175432.56789.e6     Document Type: Article

References (17)

1. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
2. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307.
3. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-1009.
4. Long-Term Intervention with Pravastatin in Ischemic Disease Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.
5. Zeiher AM, Drexler H, Saurbier B, et al. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest. 1993;92:652-662.
6. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within one month. Circulation. 1997;95:1126-1131.
7. Abetel G, Poget PN, Bonnabry JP. Hypotensive effect of and inhibitor of cholesterol synthesis (fluvastatin): a pilot study. Schweiz Med Wochenschr. 1998;1128:272-277.
8. Straznicky NE, Howes LG, Lam W, et al. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension. Am J Cardiol. 1995;75:582-586.
9. Glorioso N, Troffa C, Filigheddu F, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension. 1999; 34:1281-1286.
10. Borghi C, Prandin MG, Costa FV, et al. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol. 2000;35:549-555.
11. D'Agostino RB, Kannel WB, Stepanians MS, et al. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension. Am J Cardiol. 1993;71:82-87.
12. Muramatsu J, Kobayashi A, Hasegawa N, et al. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMGCoA reductase inhibitor pravastatin. Atherosclerosis. 1997;130: 179-182.
13. O'Callaghan CJ, Krum H, Conway EL, et al. Short-term effects of pravastatin on blood pressure in hypercholesterolaemic hypertensive patients. Blood Press. 1994;3:404-406.
14. Antonicelli R, Onorato G, Pagelli P, et al. Simvastatin in the treatment of hypercholesterolemia in elderly patients. Clin Ther. 1990;12:165-171.
15. Marcus R, Coulston AM. Water soluble vitamins. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. 1996:1555-1572.
16. Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the Pamela Study. J Hypertens. 1995;13:1377-1390.
17. Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res. 2000;47:648-657.